<DOC>
	<DOCNO>NCT00569569</DOCNO>
	<brief_summary>The treatment fibrotic choroidal neovascular lesion presence residual peripheral activity age relate macular degeneration currently present great challenge . With visual loss threatening , therapeutic option . While patient neither suitable laser therapy photodynamic therapy Verteporfin , antiangiogenic drug apply intravitreally available . Some patient however reject therapeutic option potential complication endophthalmitis frequency necessary injection . 20 patient reject intravitreal therapy treat Anecortave acetate ( Retaane® ) apply juxtascleral depot injection .</brief_summary>
	<brief_title>Retaane® Age-Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>rejection intravitreal injection presence fibrotic choroidal neovascular lesion presence residual peripheral activity age relate macular degeneration condition preclude judgement fundus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>